Cargando…
Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
SIMPLE SUMMARY: As lung cancer has the highest incidence rate compared to any other type of cancer, there have been extensive research studies aiming at finding a better treatment for curing this disease. One of the many approaches is by improving the delivery of anticancer drugs towards cancer cell...
Autores principales: | A. Razak, S. Aishah, Mohd Gazzali, Amirah, Fisol, Faisalina Ahmad, M. Abdulbaqi, Ibrahim, Parumasivam, Thaigarajan, Mohtar, Noratiqah, A. Wahab, Habibah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865793/ https://www.ncbi.nlm.nih.gov/pubmed/33499040 http://dx.doi.org/10.3390/cancers13030400 |
Ejemplares similares
-
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update
por: Abdulbaqi, Ibrahim M., et al.
Publicado: (2021) -
Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment
por: Mohtar, Noratiqah, et al.
Publicado: (2021) -
Eurycoma longifolia: an overview on the pharmacological properties for the treatment of common cancer
por: Jothi, Shankar, et al.
Publicado: (2023) -
Advances in Polyhydroxyalkanoate Nanocarriers for Effective Drug Delivery: An Overview and Challenges
por: Prakash, Priyanka, et al.
Publicado: (2022) -
Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight
por: Al-Thiabat, Mohammad G., et al.
Publicado: (2021)